Management of Infants Born with Disorders/Differences of Sex Development

Indrajit Majumdar; Tom Mazur

doi:10.1007/978-3-031-66296-6_26

Management of Infants Born with Disorders/Differences of Sex Development

Indrajit Majumdar
, Tom Mazur

Department of Psychiatry

University at Buffalo

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.

Original language	English
Title of host publication	Pediatric Endocrinology
Subtitle of host publication	A Practical Clinical Guide, Fourth Edition
Publisher	Springer Nature
Pages	721-746
Number of pages	26
ISBN (Electronic)	9783031662966
ISBN (Print)	9783031662959
DOIs	https://doi.org/10.1007/978-3-031-66296-6_26
State	Published - Jan 1 2024

Keywords

Clitoral surgery
DSD and parental reaction
DSD and quality of life
Disorders of sex development/differences of sex development
Gender change
Gender dysphoria
Legal issues globally
Medical management of DSD
Non-categorical
Shared decision making

Access to Document

10.1007/978-3-031-66296-6_26

Cite this

@inbook{66f0713b517747808de1b6fd9d0edbb9,

title = "Management of Infants Born with Disorders/Differences of Sex Development",

abstract = "Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.",

keywords = "Clitoral surgery, DSD and parental reaction, DSD and quality of life, Disorders of sex development/differences of sex development, Gender change, Gender dysphoria, Legal issues globally, Medical management of DSD, Non-categorical, Shared decision making",

author = "Indrajit Majumdar and Tom Mazur",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2003, 2013, 2018, 2024.",

year = "2024",

month = jan,

day = "1",

doi = "10.1007/978-3-031-66296-6\_26",

language = "English",

isbn = "9783031662959",

pages = "721--746",

booktitle = "Pediatric Endocrinology",

publisher = "Springer Nature",

}

TY - CHAP

T1 - Management of Infants Born with Disorders/Differences of Sex Development

AU - Majumdar, Indrajit

AU - Mazur, Tom

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2003, 2013, 2018, 2024.

PY - 2024/1/1

Y1 - 2024/1/1

N2 - Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.

AB - Precocious puberty has been a focus of interest for both the pediatric endocrinologist and the primary pediatrician for many years. The development and application of gonadotropin-releasing hormone (GnRH) agonist (GnRHa) therapy to treat central precocious puberty in the 1980s significantly changed our approach to this disorder. More recently, application of molecular biological techniques has led to a better understanding of the intricacies of regulation of gonadotropin and sex-steroid production characteristic of normal pubertal development and provided us with the tools to elucidate etiologies of previously uncharacterized disorders of precocious puberty.

KW - Clitoral surgery

KW - DSD and parental reaction

KW - DSD and quality of life

KW - Disorders of sex development/differences of sex development

KW - Gender change

KW - Gender dysphoria

KW - Legal issues globally

KW - Medical management of DSD

KW - Non-categorical

KW - Shared decision making

UR - https://www.scopus.com/pages/publications/105013015122

U2 - 10.1007/978-3-031-66296-6_26

DO - 10.1007/978-3-031-66296-6_26

M3 - Chapter

SN - 9783031662959

SP - 721

EP - 746

BT - Pediatric Endocrinology

PB - Springer Nature

ER -

Management of Infants Born with Disorders/Differences of Sex Development

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this